| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2008;118:1777-1778.)
© 2008 American Heart Association, Inc.
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery |
|---|
65 years old who had and had not received statins within 1 month of hospital discharge after CABG. Our primary outcomes were all-cause mortality and freedom from major adverse cardiovascular events. Multivariable and propensity score–adjusted analysis demonstrated that statin use within 1 month of CABG discharge independently reduced the risk of all-cause mortality (adjusted hazard ratio 0.82, 95% confidence interval 0.72 to 0.94) and major adverse cardiovascular events (adjusted hazard ratio 0.89, 95% confidence interval 0.81 to 0.98) compared with nonuse. Thus, early statin therapy independently improved postoperative outcomes, and these results confirm those of earlier studies within a contemporary surgical population. Our findings endorse the view that essentially all patients should be prescribed long-term statin therapy after CABG. See p 1785.
| Morphological and Physiological Predictors of Fetal Aortic Coarctation |
|---|
Related Articles:
Circulation 2008 118: 1828-1836.
Circulation 2008 118: 1810-1816.
Circulation 2008 118: 1817-1827.
Circulation 2008 118: 1848-1853.
Circulation 2008 118: 1802-1809.
Circulation 2008 118: 1837-1847.
Circulation 2008 118: 1785-1792.
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |